Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company,Announces Closing of $50 Million Series A Financing
- Proceeds to fund development of novel and best-in-class therapeutics for eye diseases
- Charles Semba, MD, joins the company to serve as Chief Medical Officer